| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Germano Geno J serves as a Director at ENTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 6 buys and 0 sells. Those positions are worth an estimated $298K at current prices.
Historically, Germano Geno J's trades have earned a middling insider score of 62/100 across 5 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +15.4%.
The biggest single holding is DTIL (~$298K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 12,464 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | DTIL Precision Biosciences, Inc. | Director | Buy | 2,609 | $6.28 | $16,384.52 | +5.8% | - | - | |
| Mar 9, 2026 | ENTX Entera Bio Ltd. | Director | Buy | 20,000 | $1.30 | $26,000.00 | +100.0% | -9.8% | - | |
| Feb 10, 2026 | ENTX Entera Bio Ltd. | Director | Buy | 20,000 | $1.49 | $29,800.00 | -100% | -19.3% | - | |
| Dec 16, 2025 | DTIL Precision Biosciences Inc | Director | Buy | 3,000 | $4.72 | $14,160.00 | +14.4% | +30.7% | - | |
| Mar 25, 2025 | DTIL Precision Biosciences Inc | Director | Buy | 3,250 | $5.30 | $17,225.00 | +41.6% | -11.0% | +27.1% | |
| Dec 30, 2024 | DTIL Precision Biosciences Inc | Director | Buy | 3,605 | $4.49 | $16,186.45 | +85.8% | +12.0% | +3.8% |